Publications

Publications2025-12-29T20:43:38+00:00

Latest Publications

Explore our most recent scientific milestones, peer-reviewed insights, and the impact Unicorn Biotechnologies is making in the life sciences space.

Stem Cell Therapy Boca Raton Florida: Why SB 1768 Changes Everything for Local Patients

Florida's SB 1768 legislation has revolutionized stem cell therapy access in Boca Raton, creating regulated pathways for orthopedic, wound care, and pain management treatments. Learn how this 2025 law positions local patients to access cutting-edge regenerative medicine without the risks of medical tourism.

January 19th, 2026|Categories: Uncategorized|

Alternatives to Knee Replacement Surgery: What Your Orthopedic Surgeon May Not Tell You (2026)

Up to 80% of patients told they need total knee replacement may not actually require surgery. Learn about evidence-based alternatives to knee replacement surgery that could delay or eliminate the need for surgical intervention, including specific questions to ask your orthopedic surgeon.

January 16th, 2026|Categories: Latest Publications|

Cerebral Palsy Stem Cell Therapy: Experimental Treatments vs. Proven Orthopedic Solutions

Despite 15+ years of research, no cerebral palsy stem cell therapy has received FDA approval in 2026. This guide helps families distinguish experimental neurological treatments from proven orthopedic interventions that address musculoskeletal complications of CP today.

January 16th, 2026|Categories: On-going research|

Joint Pain Supplements: When They Work, When You Need More (2026 Evidence Review)

This 2026 evidence review provides a framework for understanding when joint pain supplements deliver meaningful relief and when advanced interventions become necessary. Learn how to conduct a structured supplement trial with clear success benchmarks and navigate the treatment hierarchy from conservative options to regenerative medicine.

January 15th, 2026|Categories: Latest Publications|

Discover The Future

Committed to innovation and patient-centered solutions.

Go to Top